Tiny study hints Anti-TNF may improve sleep in ankylosing spondylitis
NCT ID NCT07441239
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study followed 18 adults with active ankylosing spondylitis who were starting anti-TNF therapy for the first time. Researchers measured their sleep quality using overnight sleep tests and a questionnaire, and tracked their daily step counts with a wearable device. The goal was to see if these measures improved after 4 months of treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- anti-TNF therapy
- What this could lead to
- If successful, this could show that anti-TNF therapy improves sleep and daily activity in people with active ankylosing spondylitis.
- What could go wrong
- This is a very small pilot study with only 18 participants and no control group, so results may not apply to everyone. It only looks at short-term changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS (AS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a 7-Minute app match a gym session for fitness and sleep?
- Ten-minute classroom workouts may boost student mental health
- Ancient practice, modern question: can tai chi ease sleep problems in older adults?
- Can we predict who sleeps poorly after heart surgery?
- Teaching teens to navigate transit may boost activity and heart health
- Could your diet shape your heart and gut health?